DarshanTalks Podcast

Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do. We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.

DarshanTalks Podcast is a science podcast hosted by Darshan Kulkarni, with 155 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Darshan Kulkarni hosts DarshanTalks Podcast, a science show with 155 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  DarshanTalks Podcast

  Is Pfizer competing with your pharmacy?

  Jan 8, 20252 minS0

  <p><b>Pharmaceutical companies, like Pfizer, are venturing into digital healthcare platforms, raising questions about competition with traditional pharmacies. Pfizer recently announced its initiative, "Pfizer for All," a digital platform that offers services such as vaccine scheduling and potential savings on medications, possibly bypassing pharmacy benefit managers (PBMs). This platform supports patients with private and government insurance, but there are concerns about how it addresses those without insurance.</b></p><p><b>The platform also enables same-day telehealth appointments with independent providers, which may raise regulatory concerns, particularly around kickbacks, given the scrutiny telehealth has faced from authorities like the...

  ListenShow Notes
• 

  DarshanTalks Podcast

  Talking to a Functional Medicine Doctor

  Jan 7, 202524 minS0

  <p><b>In this episode, guest host Kate Woods interviews Jessica Miller, who shares her journey with functional medicine, highlighting its focus on addressing root causes of illness through personalized, lifestyle-based approaches. They discuss its challenges, benefits, and empowering patients to take charge of their health.</b></p><p><b>Functional medicine focuses on addressing the root causes of illness and disease rather than simply treating symptoms, which is often the approach in traditional Western medicine. Conventional medicine tends to rely on medications to manage conditions like high blood pressure or high cholesterol without necessarily addressing underlying factors. Functional medicine...

  ListenShow Notes
• 

  DarshanTalks Podcast

  Four Types of Research related Grant Fraud

  Jan 5, 20255 minS0

  <p><b>Grant fraud encompasses four critical issues that can have severe repercussions for institutions and individuals:</b></p><b>Foreign Influence and Funding:</b><b>Failing to disclose foreign government support, as seen in Ohio State University's $875,000 settlement (November 2022).</b><b>Similar allegations against U Ming Qing Xiao in the Southern District of Illinois (April 2022).</b><b>Misrepresenting Data for Funding:</b><b>Using falsified or fabricated data to secure grants undermines the integrity of funding decisions.</b><b>The DOJ actively pursues cases, as demonstrated in Duke University’s case (March 2019).</b><b>Misrepresenting Data Arising from Grants:</b>...

  ListenShow Notes
• 

  DarshanTalks Podcast

  🔒 Leveraging AI and RWD to Reshape Drug Trials!

  Jan 3, 20255 minS0

  <p>Subscriber-only episode</p><p><b>In this episode, Darshan explores how artificial intelligence (AI) is transforming clinical trial design, with a focus on using real-world data (RWD). The episode dives into the FDA’s recognition of AI’s potential to enhance clinical trials by using data from electronic health records (EHRs), medical claims, and disease registries. AI’s ability to analyze large data sets enables identification of patterns that can predict chronic disease progression, leading to more personalized and effective treatments.</b></p><p><b>Key benefits discussed include AI's role in continuous monitoring of trial subjects, real-time data analys...

  ListenShow Notes
• 

  DarshanTalks Podcast

  DCTs in Oncology: Can They Work?

  Jan 1, 202512 minS0

  <p><b>The FDA’s 2024 guidance on decentralized clinical trials (DCTs) has the potential to transform clinical research, particularly in oncology. While many still view DCTs as either fully virtual or fully in-person, the guidance promotes a hybrid approach, blending traditional and decentralized elements. This flexibility may help smaller sites participate alongside large academic medical centers, making trials more accessible to rural and underserved areas.</b></p><p><b>However, challenges remain, including regulatory complexities, patient safety concerns, and infrastructure demands—especially for oncology studies, which are inherently intricate and costly. The FDA’s choice to issue nonbinding guidance rather than e...

  ListenShow Notes

Recent guests on DarshanTalks Podcast. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.